Target intelligence / Profile preview

Cytochrome b5 type B pseudogene

Molecular classification: Pseudogene

Overview

The cytochrome b5 type B pseudogene (ENSG00000259509, LOC112268162) is a retrotransposed, non-functional genetic element in the human genome, derived from the CYB5B gene encoding cytochrome b5 type B[3]. While the functional cytochrome b5 type B protein is involved in electron transfer within mitochondrial membranes[11], this pseudogene lacks introns and is presumed to result from retroviral insertion events[3]. It does not produce functional protein, does not participate in physiological or pathological processes, and is not considered a valid therapeutic target.

Other names: LOC112268162ENSG00000259509cytochrome b5 pseudogene

Beyond the preview

Go deeper on Cytochrome b5 type B pseudogene.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Explore the programs pursuing this target and their development progress.

Drug candidates
Developers
Development stage

Clinical trials

Follow the clinical studies evaluating therapies directed at this target.

Trial design
Status
Readouts

Competitive landscape

Compare approaches across drug candidates, modalities, and indications.

Programs
Modalities
Indications

Literature & evidence

Investigate the research and source evidence behind target biology and development.

Publications
Sources
Analysis

Patents

Explore patent activity around therapies and technologies addressing this target.

Patents
Assignees
Technologies

Research & analysis

Connect target biology, drug development, and emerging evidence in your research.

Biology
Development news
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Cytochrome b5 type B pseudogene.

Explore the full profile